%0 Journal Article %T First-line immunotherapy for patients with advanced stage or metastatic non-small cell lung cancer…finally what threshold of PD-L1 expression on tumor cells? %A Hofman, Paul %J Translational Lung Cancer Research %D 2019 %B 2019 %9 %! First-line immunotherapy for patients with advanced stage or metastatic non-small cell lung cancer…finally what threshold of PD-L1 expression on tumor cells? %K %X A certain number of patients with advanced stage or metastatic non-small cell lung cancer (NSCLC) show better overall survival when treated with first-line immunotherapy than patients treated with chemotherapy (1). This finding, originally reported in KEYNOTE-024, has just been updated and continues to confirm, for the same cohort of patients, benefit from first-line pembrolizumab treatment (1,2). %U https://tlcr.amegroups.org/article/view/28754 %V 8 %N 5 %P 728-730 %@ 2226-4477